Literature DB >> 9335043

Laying the foundations for personalized medicines.

A Marshall.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9335043     DOI: 10.1038/nbt1097-954

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Review of "angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II".

Authors:  N J Schork
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

2.  Treatment Heterogeneity and Individual Qualitative Interaction.

Authors:  Robert S Poulson; Gary L Gadbury; David B Allison
Journal:  Am Stat       Date:  2012-06-12       Impact factor: 8.710

3.  Genetic variation and pharmacogenomics: concepts, facts, and challenges.

Authors:  Margret R Hoehe; Thomas Kroslak
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

4.  PharmGED: Pharmacogenetic Effect Database.

Authors:  C J Zheng; L Y Han; B Xie; C Y Liew; S Ong; J Cui; H L Zhang; Z Q Tang; S H Gan; L Jiang; Y Z Chen
Journal:  Nucleic Acids Res       Date:  2006-12-06       Impact factor: 16.971

Review 5.  Social pharmacology: expanding horizons.

Authors:  Rituparna Maiti; José Luis Alloza
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

6.  Conceptual and terminological confusion around personalised medicine: a coping strategy.

Authors:  Giovanni De Grandis; Vidar Halgunset
Journal:  BMC Med Ethics       Date:  2016-07-18       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.